The board of directors at Adjuvant Capital is experienced in a variety of industries and has a wealth of education between them. They have been board members at companies such as Maternal Newborn Health Innovations and Revelation Biosciences Inc., and have also been managing partners and advisors at AXA IM Global Health Fund and AXA IM Prime Impact Fund respectively. This experience and knowledge is sure to be a valuable asset to the company.
View all